HR Positive/HER-2 Negative Breast Cancer trials recruiting in New Jersey

Fewer than 3 recruiting trials found.

All HR Positive/HER-2 Negative Breast Cancer trials nationally

Cities in New Jersey

Recruiting trials in New Jersey

• A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
  NCT07383506 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: East Brunswick
• Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
  NCT07211178 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · New Jersey: Florham Park